Comparative Bactericidal Activity Of Representative B-Lactams
B-Lactam sub-classes (penicillins, cephalosporins, monobactams and carbapenems) have different antibacterial effects against E. coli, K. pneumoniae, A. baumannii and P. aeruginosa.
Summary
Comparative Bactericidal Activity Of Representative ß-Lactams Against Enterobacterales, Acinetobacter Baumannii and Pseudomonas Aeruginosa
[Posted 25/May/2022]
AUDIENCE: Infectious Disease, Internal Medicine
KEY FINDINGS: ß-Lactam sub-classes (penicillins, cephalosporins, monobactams and carbapenems) have different antibacterial effects against E. coli, K. pneumoniae, A. baumannii and P. aeruginosa. Extrapolation of in vitro pharmacodynamic findings from one species to another or one sub-class of ß-lactam to another is not justified.
BACKGROUND: There is surprisingly little comparative published data on the bactericidal action of different sub-classes of ß-lactams against aerobic Gram-negative rods, and the assumption is that all behave in the same way. Purpose of this study is to describe a systematic investigation of a representative penicillin, cephalosporin, monobactam and carbapenem against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa.
DETAILS: Concentration-time-kill curves (TKC) were determined for three strains each of E. coli, K. pneumoniae, A. baumannii and P. aeruginosa. All strains were susceptible to the agents used. The antibiotics were piperacillin/tazobactam, ceftazidime, aztreonam and meropenem. The initial inoculum was 106 cfu/mL and TKC were determined over 48 h. The area-under-the-bacterial-kill curve to 24 h (AUBKC 24 log cfu.h/mL) and 48 h (AUBKC 48) were used to measure antibacterial effect (ABE). Population profiles before and after antibiotic exposure were recorded. Against E. coli and K. pneumoniae meropenem had a maximal ABE at >=MIC x 1 concentrations while piperacillin/tazobactam and ceftazidime had maximal effect at >=MIC x 4 and aztreonam at >=MIC x 8 concentrations. Ceftazidime, aztreonam and meropenem had less ABE against K. pneumoniae than E. coli. Against P. aeruginosa, meropenem was most bactericidal, with a maximum ABE at 8x/16 x MIC. Other ß-lactams had notably less ABE. In contrast, against A. baumannii, ceftazidime and meropenem had the greatest ABE, with a maximal effect at >=MIC x 4, concentration changes in population profiles were least apparent with E. coli.
Our Most Popular Resources
Copyright © Oxford University Press. All rights reserved.
Source: Noel, A. R., Attwood, M., Bowker, K. E., et al. (2022). Comparative Bactericidal Activity Of Representative ß-Lactams Against Enterobacterales, Acinetobacter Baumannii and Pseudomonas Aeruginosa. Journal of Antimicrobial Chemotherapy. 2022; 77(5): 1306-1312. Published: May, 2022. DOI: 10.1093/jac/dkac026.
Promising Drug Candidates and Emerging Therapeutic Strategies Against Candida auris
Emerging therapies for Candida auris extend beyond conventional antifungal agents and include repurposed drugs, novel antifungal compounds, vaccines, antimicrobial peptides, and nanotechnology-based approaches. While further clinical validation is needed, these strategies may help address the growing challenge of multidrug-resistant C. auris infections.
Our Most Popular Resources
Ambulatory Antibiotic Prescribing for Acute Sinusitis
Overall, approximately one-third of patients with acute sinusitis did not meet guideline-based indications for antibiotic therapy, yet antibiotics continued to be prescribed frequently in this population. These findings highlight opportunities for antimicrobial stewardship initiatives to improve both prescribing frequency and treatment duration, particularly in clinical settings where adherence to recommended practices is suboptimal, while monitoring potential unintended effects such as repeat healthcare utilization.
Our Most Popular Resources
Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks
Findings suggest intensive chemoprophylaxis of 70% or more of residents in response to influenza outbreaks in NHs within the first 2 days is associated with a lower 14-day risk of hospitalization among residents, with additional evidence to support a benefit when 60% or more or 80% or more of residents receive chemoprophylaxis. These findings could strengthen evidence-based recommendations to inform best practices in managing influenza outbreaks in NHs.
Our Most Popular Resources
Efficacy of Low-Dose Oral Isotretinoin Combined with Fractional Microneedle Radiofrequency Versus Low-Dose Oral Isotretinoin Monotherapy in the Treatment of Moderate-To-Severe Acne Vulgaris
Early active treatment with isotretinoin and FMRF is safe and better than isotretinoin monotherapy over 44 weeks regarding severity, reduced erythema, and improved surface roughness in moderate-to-severe acne vulgaris. This encourages early and effective treatment of acne to mitigate acne scarring and improve patients' quality of life.
Our Most Popular Resources
Long-Term Control of Human Papillomavirus-Related Focal Epithelial Hyperplasia in an Human Immunodeficiency Virus-Positive Patient Using Methylene Blue-Mediated Photodynamic Therapy
Topical MB-mediated PDT successfully managed HPV-related FEH in an immunocompromised individual with history of valve disease. This outcome supports the need for further validation through clinical trials.
Our Most Popular Resources
Specialty: